Clinical Trial Update: Lopinavir/Ritonavir or Efavirenz as First-line Antiretroviral Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating first-line antiretroviral therapy using Lopinavir/ritonavir versus Efavirenz for HIV infection; the study status is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)
• Sustiva (efavirenz)

Snippet

Sponsor: UPECLIN HC FM Botucatu Unesp | Conditions: HIV Infections | Phase 4 | Status: UNKNOWN